register

News & Trends - MedTech & Diagnostics

Medical devices industry delivers savings according to new report

Health Industry Hub | May 20, 2020 |

MedTech News: The March 2020 quarter statistics on Private Health Insurance highlight once again the savings that have been delivered by MTAA’s Agreement with the Commonwealth, despite the enormous financial pressures being faced by the medical devices industry as a result of the COVID-19 pandemic.

According to the Australian Prudential Regulation Authority (APRA) statistics, the total benefits paid for prostheses decreased by 10.9% in the March quarter compared to the December quarter 2019.

This is a direct result of the $1.1 billion dollars in cuts that MTAA delivered through its October 2017 Agreement, and a crucial demonstration of the significant contribution that MTAA is making towards affordable health care.

“Our Agreement with the Commonwealth is delivering real and tangible outcomes as we continue to work to hand-in-glove with federal and state governments to supply critical medical equipment,” said Ian Burgess, MTAA CEO, today.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“Through $1.1 billion in cuts, we have demonstrated that the medical device industry is willing to work collaboratively with all stakeholders to deliver value and affordability to consumers.

“Despite facing unprecedented financial pressures, including an increase in freight costs of up to 600%, revenue reductions of up to 90% and a falling Australian dollar, the medtech has industry has worked tirelessly to ensure supply throughout the COVID-19 pandemic,” Mr Burgess said.

The APRA data shows private health insurers continuing to enjoy strong profitability, which is expected to increase significantly as a result of the temporary pause in elective surgery, with premiums set to go up at the end of 2020.

“We will continue to deliver the savings that were promised as we expedite the manufacture and supply of crucial medical equipment to the frontline of the fight against COVID-19, which remains the number one priority of our members,” Mr Burgess concluded.

In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech and ARCS Australia. Learn more.


News & Trends - Pharmaceuticals

Roche's immunotherapy drug shows promising results for Australian patients with rare blood cancer

Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer

Health Industry Hub | October 8, 2024 |

Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]

More


News & Trends - Pharmaceuticals

Government seals deal with industry for rare cancer therapy

Government seals deal with industry for rare cancer therapy

Health Industry Hub | October 8, 2024 |

Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]

More


News & Trends - MedTech & Diagnostics

Abbott showcases leadless pacemaker system to local stakeholders

Abbott showcases leadless pacemaker system to local stakeholders

Health Industry Hub | October 8, 2024 |

MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]

More


News & Trends - Pharmaceuticals

Australian scientists pivotal in new drug class from BMS

Australian scientists pivotal in new drug class from BMS

Health Industry Hub | October 8, 2024 |

Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]

More


This content is copyright protected. Please subscribe to gain access.